Moreover, in GBA-PD brains, the fraction of GBA that fails to fold in the ER is targeted to the lysosomes, which has been shown to inhibit lysosome-associated membrane protein 2 (LAMP2A) multimerization, subsequently blocking degradation of other CMA substrates, including α-synuclein. The gene discussed is GBA1; the disease is Parkinson disease.